T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy
US8765683B2 · kind B2 · utility
1Cited by
20References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2012 |
| Grant date | Jul 1, 2014 |
| Priority date | — |
| Expiry date | Jan 29, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel therapeutic uses of T-140 analog peptides and compositions comprising same. Specifically, the invention provides compositions and methods useful in cancer therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.